Ipamorelin + CJC-1295: vial math
Research reference only. Source-reported examples and schedules are not dosing recommendations from MGMT Research. They do not establish safety or suitability. Prescribed medication decisions belong with a licensed clinician and the current product label.
— mL · U-100
Syringe markings measure volume. They are not IU of the compound. Calculations do not account for handling losses or product stability.
— mL · U-100
Syringe markings measure volume. They are not IU of the compound. Calculations do not account for handling losses or product stability.
Reference notes
Use an individual calculation for each separate vial. A premixed product belongs in a blend calculation using the labelled total and ratio.
The source discusses simultaneous administration one or more times daily; that statement describes its content and does not establish a validated MGMT regimen.
| Compound | Vial | Diluent | Concentration | Units (mL) |
|---|---|---|---|---|
| Ipamorelin | 2 mg | 2.5 mL | 0.8 mg/mL | 25 (0.25) |
| Ipamorelin | 5 mg | 2.5 mL | 2 mg/mL | 10 (0.1) |
| CJC-1295 no DAC | 2 mg | 2 mL | 1 mg/mL | 20 (0.2) |
| CJC-1295 no DAC | 5 mg | 2 mL | 2.5 mg/mL | 8 (0.08) |
| CJC-1295 no DAC | 10 mg | 2 mL | 5 mg/mL | 4 (0.04) |
Source & content review 2 notes
This is an original, concise draft. Full information and numerical parity with the source is not yet established.
Open source reference ↗- Source numeric coverage is partial: selected reference values are preserved; all additional source tables and examples still require reconciliation before claiming full fidelity.
- Source rounds mL separately from U-100 units. Do not silently replace its displayed values. Exact-volume calculator behavior and source-display precision require review.
Captured source values
{
"numericalFacts": []
}